Rgenix

Rgenix

Rgenix

Rgenix is a preclinical stage pharmaceutical company with a mission to develop the world's first cancer therapies designed specifically to target cancer metastasis, the main cause of mortality in cancer patients.
Founded
2010
Raised
$33M
Follow us
Alexa global traffic share